150 related articles for article (PubMed ID: 33144282)
21. Contribution of an extensive medication-based comorbidity index (Rx-Risk) in explaining the excess mortality after hip fracture in older Norwegians: a NOREPOS cohort study.
Holvik K; Hjellvik V; Karlstad Ø; Gunnes N; Hoff M; Tell GS; Meyer HE
BMJ Open; 2022 May; 12(5):e057823. PubMed ID: 35501100
[TBL] [Abstract][Full Text] [Related]
22. Comments on a recent case-control study of malignant mesothelioma of the pericardium and the tunica vaginalis testis.
Mezei G; Chang ET; Mowat FS; Moolgavkar SH
Scand J Work Environ Health; 2021 Jan; 47(1):85-86. PubMed ID: 32626907
[TBL] [Abstract][Full Text] [Related]
23. Screening pharmaceuticals for possible carcinogenic effects: initial positive results for drugs not previously screened.
Friedman GD; Udaltsova N; Chan J; Quesenberry CP; Habel LA
Cancer Causes Control; 2009 Dec; 20(10):1821-35. PubMed ID: 19582585
[TBL] [Abstract][Full Text] [Related]
24. Recall bias in melanoma risk factors and measurement error effects: a nested case-control study within the Norwegian Women and Cancer Study.
Parr CL; Hjartåker A; Laake P; Lund E; Veierød MB
Am J Epidemiol; 2009 Feb; 169(3):257-66. PubMed ID: 19011116
[TBL] [Abstract][Full Text] [Related]
25. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
[TBL] [Abstract][Full Text] [Related]
26. Authors' response: Mezei et al's "Comments on a recent case-control study of malignant mesothelioma of the pericardium and the tunica vaginalis testis".
Marinaccio A; Consonni D; Mensi C; Mirabelli D; Migliore E; Magnani C; Di Marzio D; Gennaro V; Mazzoleni G; Girardi P; Negro C; Romanelli A; Chellini E; Grappasonni I; Madeo G; Romeo E; Ascoli V; Carrozza F; Angelillo IF; Cavone D; Tumino R; Melis M; Curti S; Brandi G; Mattioli S; Iavicoli S;
Scand J Work Environ Health; 2021 Jan; 47(1):87-89. PubMed ID: 33388783
[TBL] [Abstract][Full Text] [Related]
27. Use of antihypertensive drugs and risk of cutaneous melanoma: a nationwide nested case-control study.
Ghiasvand R; Berge LAM; Andreassen BK; Stenehjem JS; Heir T; Karlstad Ø; Juzeniene A; Larsen IK; Green AC; Veierød MB; Robsahm TE
Int J Epidemiol; 2023 Jun; 52(3):887-898. PubMed ID: 36413027
[TBL] [Abstract][Full Text] [Related]
28. Proton pump inhibitors and fracture risk. The HUNT study, Norway.
Hoff M; Skovlund E; Skurtveit S; Meyer HE; Langhammer A; Søgaard AJ; Syversen U; Forsmo S; Abrahamsen B; Schei B
Osteoporos Int; 2020 Jan; 31(1):109-118. PubMed ID: 31741023
[TBL] [Abstract][Full Text] [Related]
29. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
30. Cross-sectional survey of off-label and unlicensed prescribing for inpatients at a paediatric teaching hospital in Western Australia.
Landwehr C; Richardson J; Bint L; Parsons R; Sunderland B; Czarniak P
PLoS One; 2019; 14(1):e0210237. PubMed ID: 30620749
[TBL] [Abstract][Full Text] [Related]
31. Reproductive factors and risk of melanoma: a population-based cohort study.
Støer NC; Botteri E; Ghiasvand R; Busund M; Vangen S; Lund E; Veierød MB; Weiderpass E
Br J Dermatol; 2019 Aug; 181(2):282-289. PubMed ID: 30748007
[TBL] [Abstract][Full Text] [Related]
32. METASTATIC NODULAR MELANOMA DEVELOPING ON NEVUS SPILUS DURING INTAKE OF BETA BLOCKERS (BISOPROLOL/NEBIVOLOL) AND ACE INHIBITORS (PERINDOPRIL). POTENTIAL LINKS TО THE DRUG RELATED NITROSOGENESIS/CARCINOGENESIS, DUNNING-KRUGER EFFECT AND GENETIC WEAPONS OF THE NEW GENERATION.
Tchernev G
Georgian Med News; 2023 Oct; (343):172-178. PubMed ID: 38096536
[TBL] [Abstract][Full Text] [Related]
33. Association of Phenotypic Characteristics and UV Radiation Exposure With Risk of Melanoma on Different Body Sites.
Ghiasvand R; Robsahm TE; Green AC; Rueegg CS; Weiderpass E; Lund E; Veierød MB
JAMA Dermatol; 2019 Jan; 155(1):39-49. PubMed ID: 30477003
[TBL] [Abstract][Full Text] [Related]
34. Histological type and grade of breast cancer tumors by parity, age at birth, and time since birth: a register-based study in Norway.
Albrektsen G; Heuch I; Thoresen SØ
BMC Cancer; 2010 May; 10():226. PubMed ID: 20492657
[TBL] [Abstract][Full Text] [Related]
35. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
Pukkala E; Martinsen JI; Lynge E; Gunnarsdottir HK; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K
Acta Oncol; 2009; 48(5):646-790. PubMed ID: 19925375
[TBL] [Abstract][Full Text] [Related]
36. Comparison of cancer incidence in Norway and Arkhangelskaja Oblast in Russia.
Vaktskjold A; Lebedintseva J; Korotov D; Podjakova T; Tkatsjov A; Lund E
Alaska Med; 2007; 49(2 Suppl):99-104. PubMed ID: 17929616
[TBL] [Abstract][Full Text] [Related]
37. Hyperemesis gravidarum and risk of cancer in offspring, a Scandinavian registry-based nested case-control study.
Vandraas KF; Vikanes ÅV; Støer NC; Troisi R; Stephansson O; Sørensen HT; Vangen S; Magnus P; Grjibovski AM; Grotmol T
BMC Cancer; 2015 May; 15():398. PubMed ID: 25963309
[TBL] [Abstract][Full Text] [Related]
38. Risk of breast cancer following fertility treatment--a registry based cohort study of parous women in Norway.
Reigstad MM; Larsen IK; Myklebust TÅ; Robsahm TE; Oldereid NB; Omland AK; Vangen S; Brinton LA; Storeng R
Int J Cancer; 2015 Mar; 136(5):1140-8. PubMed ID: 25042052
[TBL] [Abstract][Full Text] [Related]
39. Sex differences in rising trends of cutaneous malignant melanoma in Norway, 1954-2008.
Robsahm TE; Bergva G; Hestvik UE; Møller B
Melanoma Res; 2013 Feb; 23(1):70-8. PubMed ID: 23222548
[TBL] [Abstract][Full Text] [Related]
40. A sudden and unprecedented increase in low dose naltrexone (LDN) prescribing in Norway. Patient and prescriber characteristics, and dispense patterns. A drug utilization cohort study.
Raknes G; Småbrekke L
Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):136-142. PubMed ID: 27670755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
